Myhre–Ruvalcaba–Kelley syndrome
Myhre–Ruvalcaba–Kelley syndrome is a rare genetic disorder characterized by a range of physical anomalies and developmental delays. This syndrome is part of a group of conditions known as genetic disorders, which are caused by changes to genes or chromosomes. Myhre–Ruvalcaba–Kelley syndrome is notable for its complex presentation, which can include skeletal abnormalities, skin anomalies, and intellectual disability among other symptoms.
Symptoms and Characteristics[edit | edit source]
The clinical presentation of Myhre–Ruvalcaba–Kelley syndrome can vary significantly among affected individuals. Common symptoms and characteristics include:
- Growth abnormalities: Individuals may exhibit short stature due to growth delays.
- Skeletal anomalies: These can include thickened bones, particularly in the skull, and joint stiffness.
- Skin abnormalities: Patients often have thick, tight skin and may experience abnormal scarring.
- Intellectual disability: Varying degrees of intellectual impairment may be present.
- Facial dysmorphisms: Distinctive facial features such as a broad nasal bridge, deep-set eyes, and a small mouth may be observed.
Causes[edit | edit source]
Myhre–Ruvalcaba–Kelley syndrome is a genetic condition, though the specific genetic mutations responsible for its manifestation are not fully understood. It is believed to follow an autosomal dominant inheritance pattern, where a single copy of the altered gene in each cell is sufficient to cause the disorder. However, cases have been reported where there is no known family history of the syndrome, suggesting the possibility of new mutations.
Diagnosis[edit | edit source]
Diagnosis of Myhre–Ruvalcaba–Kelley syndrome is primarily based on clinical evaluation and the identification of characteristic symptoms. Genetic testing may help confirm the diagnosis but is not always conclusive due to the rarity of the syndrome and the potential for novel mutations.
Treatment[edit | edit source]
There is no cure for Myhre–Ruvalcaba–Kelley syndrome, and treatment is symptomatic and supportive. Management strategies may include:
- Physical therapy: To improve joint stiffness and mobility.
- Surgical interventions: For skeletal anomalies and to address specific physical complications.
- Educational support: Tailored educational programs can help address developmental delays and intellectual disability.
Prognosis[edit | edit source]
The prognosis for individuals with Myhre–Ruvalcaba–Kelley syndrome varies depending on the severity of symptoms and the presence of associated health issues. With appropriate management and supportive care, individuals can lead fulfilling lives.
See Also[edit | edit source]
Myhre–Ruvalcaba–Kelley syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD